Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 4, 2000, Pages 1040-1046

  Chan, Jason R ^a   Böger, Rainer H ^a   Bode Böger, Stefanie M ^a   Tangphao, Oranee ^a   Tsao, Philip S ^a   Blaschke, Terrence F ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Endothelium; L arginine; Monocytes; T lymphocytes

Indexed keywords

ARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE;

ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0342369520     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.4.1040     Document Type: Article

References (53)

1. Libby P, Hansson GK. Involvement of the immune system in human atherosclerosis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-15.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
3. Gimbrone MA Jr. Vascular endothelium: an integrator of pathophysiologic, stimuli in atherosclerosis. Am J Cardiol. 1995;75:67B-70B.
4. Jongkind JF, Verkerk A, Hoogebrugge N. Monocytes from patients with combined hypercholesterolemia-hypertriglyceridemia and isolated hypercholesterolemia show an increased adhesion to endothelial cells in vitro, III: influence of intrinsic and extrinsic factors on monocyte binding. Metabolism. 1995;44:374-378.
5. Theilmeier G, Chan JR, Zalpour C, Anderson B, Wang B-Y, Wolf A, McEvoy LM, Butcher EC, Tsao PS, Cooke JP. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine. Arterioscler Thromb Vasc Biol. 1997;17:3557-3564.
6. Rothe G, Gabriell H, Kovacs E, Klucken J, Stohr J, Kindermann W, Schmitz G. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1996;16:1437-1447.
7. Stemme S, Hansson GK. Immune mechanisms in atherogenesis. Ann Med. 1994;26:141-146.
8. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85: 1260-1266.
9. Couffinhal T, Duplaa C, Labat L, Moreau C, Bietz I, Bonnet J. Effect of low density lipoprotein on monocyte adhesiveness to endothelial cells in vitro. Atherosclerosis. 1993;99:35-45.
10. Lorant DE, Zimmerman GA, McIntyre TM, Prescott SM. Platelet activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. Semin Cell Dev Biol. 1996;6: 295-303.
11. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto AM Jr, Ballantyne CM. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 1996;93:1334-1338.
12. Gauthier TW, Scalia R, Murohara T, Guo JP, Lefer AM. Nitric oxide protects against leukocyte-endothelial interaction of early hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995;15:1652-1659.
13. Pohl U, Busse R. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed. Circ Res. 1989;65:1798-1803.
14. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;337: 572-757.
15. Jin JS, D'Alecy LG. Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor. J Cardiovasc Pharmacol. 1996;28:439-446.
16. Ghosh SK, Paik WK, Kim S. Purification and molecular identification of two protein methylases I from calf brain: myelin basic protein-and histone-specific enzyme. J Biol Chem. 1988;263:19024-19033.
17. G-dimethylarginine in the rabbit. Biochem J. 1976;154:179-184.
18. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98:1842-1847.
19. Bath PM, Hassall DG, Gladwin AM, Palmer RM, Martin JF. Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 1991;11:254-260.
20. Friedwald WT, Levi RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in the plasma without the use of the preparative ultracentrifuge. Clin Chem. 1958;18:499-502.
21. Bode-Boger SM, Boger RH, Kienke S, Junker W, Frolich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun. 1996;219;598-603.
22. Takahashi K, Sawasaki Y, Hata JI, Mukai K, Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol. 1990;25:265-274.
23. Takahashi K, Sawasaki Y. Rare spontaneously transformed human endothelial cell line provides useful research tool. In Vitro Cell Dev Biol. 1992;28A:380-382.
24. Lehr HA, Hubner C, Nolte D, Finckh B, Beisiegel U, Kohlschutter A, Messmer K. Oxidatively modified human low-density lipoprotein stimulates leukocyte adherence to the microvascular endothelium in vivo. Res Exp. Med (Berl). 1991;191:85-90.
25. Lehr HA, Becker M, Marklynd SL, Hubner C, Arfors KE, Kohlschutter A, Messmer K. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arterioscler Thromb. 1992;12:824-829.
26. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol. 1975;66:188-193.
27. Tedder TF, Steeber DA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J. 1995;9:866-873.
28. Jutila MA, Kishimoto TK, Butcher EC. Regulation and lectin activity of the human neutrophil peripheral lymph node homing receptor. Blood. 1990;76:178-183.
29. Kishimoto TK, Jutila MA, Butcher EC. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad Sci USA. 1990;87:2244-2248.
30. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327:524-526.
31. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988;153:1251-1256.
32. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA. 1991;88:10480-10484.
33. Cooke JP, Singer AH, Tsao PS, Zera P, Rowan RA, Billingham ME. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
34. Boger RH, Bode-Boger SM, Mugge A, Kienke S, Brandes R, Dwenger A, Frolich JC. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995;117:273-284.
35. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 1994;89:2176-2182.
36. Tsao PS, Theilmeler G, Singer AH, Leung LL, Cooke JP. L-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:1529-1533.
37. Wang BY, Singer AH, Tsao PS, Drexler H, Kosek J Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol. 1994;23:452-458.
38. Candipan RC, Wang BY, Buitrago R, Tsao PS, Cooke JP. Regression or progression: dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol. 1996;16:44-50.
39. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A. Celermajer DS, Deanfield JE. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 1996;97:1989-1994.
40. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:1248-1253.
41. Hansson GK, Seifert PS, Olsson G, Bondjers G. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb. 1991;11:745-750.
42. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 1993;13:197-204.
43. Sakai A, Kume N, Nishi E, Tanoue K, Miyasaka M, Kita T. P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimai accumulation of macrophages and T lymphocytes. Arterioscler Thromb Vasc Biol. 1997;17:310-316.
44. Weber C, Alon R, Moser B, Springer TA. Sequential regulation of alpha 4 beta 1 and alpha 5 beta I integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J Cell Biol. 1996;134:1063-1073.
45. Mahmoodi H, Hadley M, Chang YX, Draper HH. Increased formation and degradation of malondialdehyde-modified proteins under conditions of peroxidative stress. Lipids. 1995;30:963-966.
46. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, Whitley G S, Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol. 1996;119: 1533-1540.
47. Weidinger FF, McLenachan JM, Cybulsky MI, Fallon JT, Hollenberg NX, Cooke JP, Ganz P. Hypercholesterolemia enhances macrophage recruitment and dysfunction of regenerated endothelium after balloon injury of the rabbit iliac artery. Circulation. 1991;84:755-767.
48. Azuma H, Saw J, Hamadaki H, Sugimoto A, Isotani E, Obayashi S. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br J Pharmacol. 1995;115:1001-1004.
49. G′-dimethylarginine by human endothelial cells. Endothelium. 1993;1:137-140.
50. Faraci FM, Brian JE Jr, Heistad DD. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol 1995; 269(pt 2):H1522-H1527.
51. Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 1997;95:2068-2074.
52. Theilmeier G, Chan J, Zalpour C, Ma A, Anderson B, Wang B-Y, Wolf A, McEvoy L, Butcher E, Tsao PS, Cooke JP. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary arginine. Arterioscler Thromb Vasc Biol. 1997;17:3557-3564.
53. Giugliano D, Marfella R, Verrazo G, Acampora R, Coppola L, Cozzolino D, D'Onofrio F. The vascular effects of L-arginine in humans: the role of endogenous insulin. J Clin Invest. 1997;99:433-438.